Literature DB >> 2936114

Levuglandins: isolation, characterization, and total synthesis of new secoprostanoid products from prostaglandin endoperoxides.

R G Salomon, D B Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2936114

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  23 in total

Review 1.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

2.  Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Authors:  Casey Charvet; Wei-Li Liao; Gun-Young Heo; James Laird; Robert G Salomon; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

4.  Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.

Authors:  Lilu Guo; Stephen D Gragg; Zhongyi Chen; Yongqin Zhang; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2013-09-09       Impact factor: 5.922

Review 5.  Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.

Authors:  Kala B Dixon; Sean S Davies; Annet Kirabo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-16       Impact factor: 4.733

Review 6.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.

Authors:  Liang Xiao; David M Patrick; Luul A Aden; Annet Kirabo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-29       Impact factor: 3.072

7.  Isoketals form cytotoxic phosphatidylethanolamine adducts in cells.

Authors:  C Blake Sullivan; Elena Matafonova; L Jackson Roberts; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2009-11-25       Impact factor: 5.922

Review 8.  Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics.

Authors:  Bharathi Govindarajan; James Laird; Ronald Sherman; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

10.  Increased isolevuglandin-modified proteins in glaucomatous astrocytes.

Authors:  Bharathi Govindarajan; Anna Junk; Mabel Algeciras; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.